Major Interest in Shares

RNS Number : 9249Z
Alliance Pharma PLC
21 January 2011
 



For immediate release 

21 January 2011

 

Alliance Pharma plc

 

TR-1: Notification of major interest in shares

 

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:

Alliance Pharma  plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights


An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify):

On market transfer between direct and indirect funds

YES

3. Full name of person(s) subject to the
notification obligation:

Aviva plc and its subsidiaries

4. Full name of shareholder(s)
 (if different from 3.):

Registered Holder:

 

BNY Norwich Union Nominees Limited               2,161,425*   

 

Chase (GA Group) Nominees Limited                13,192,709*

 

CUIM Nominee Limited                                      2,031,377*

                                                             

*denotes direct interest

 

BNP Paribas - London                                      1,546,572

 

Chase Nominees Limited                                  5,384,672

 

5. Date of the transaction and date on
which the threshold is crossed or
reached:

20 January 2011

6. Date on which issuer notified:

21 January 2011

7. Threshold(s) that is/are crossed or
reached:

5% to 7% Change at Direct Interest Level

 

8. Notified details:

A: Voting rights attached to shares

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights

Direct

Direct

Indirect

Direct

Indirect

GB0031030819

Direct:

13,962,660

(5.94%)

Indirect:

10,354,095

(4.41%)

Direct:

13,962,660

(5.94%)

Indirect:

10,354,095

(4.41%)

24,316,755

17,385,511

6,931,244

7.36%

2.93%



B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date

Exercise/
Conversion Period

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights







C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date

Exercise/
Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 





 

 

Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

24,316,755

10.29%



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

 

 


Proxy Voting:

10. Name of the proxy holder:

See section 4

11. Number of voting rights proxy holder will cease
to hold:


12. Date on which proxy holder will cease to hold
voting rights:




13. Additional information:


Figures are based on a revised total number of voting rights of 236,200,656

14. Contact name:

Neil Whittaker, Aviva plc

15. Contact telephone number:

01603 684420

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLSEWFWFFFSELF
UK 100

Latest directors dealings